Lactobacillus plantarum.

Plantarum ferments fructans such as inulin to lactate, lowering colonic pH and shifting the local community. Supplying the strain with its substrate is the core synbiotic idea.

Partially hydrolysed guar gum ferments gradually along the colon and feeds lactic acid bacteria without adding thickness to a drink. That makes it the usual carrier fibre in strain blends.

Pectin is fermented into short-chain fatty acids by lactic acid bacteria and its gel slows transit, extending contact between organisms and substrate.

Oat beta-glucan arrives in the colon intact and is fermented by lactic acid bacteria, adding to lactate output. Its viscosity in the upper gut also changes transit speed.

Lactate produced by plantarum is taken up by butyrate-forming bacteria and converted onward, linking the two metabolites in one cross-feeding chain. Direct butyrate covers the downstream product.

Glutamine fuels intestinal cells and supports normal tight-junction protein expression, acting on the host side while the strain acts in the lumen. Both target the same barrier.

Colostrum supplies secretory immunoglobulins along with milk oligosaccharides that lactic acid bacteria ferment. The pairing has a long history in gut-support formulas.

Plantarum carries beta-galactosidase and breaks down some lactose itself, working on the same substrate as a supplemental lactase. The two routes are additive on that sugar.

Several Lactobacillus plantarum strains carry the folate biosynthesis operon and release folate into the medium, which is why they are used in fermented food folate work. Strain identity decides whether the capacity is present.

Carvacrol and thymol damage bacterial membranes without selectivity, so a simultaneous dose lowers the surviving count of a delivered strain. Separating the two by several hours is the usual practice.

Berberine acts directly on gut bacteria and reshapes community composition, which pulls against a live-organism dose taken at the same moment. Staggered dosing is the standard handling.

Charcoal adsorbs organic molecules across the board in the gut lumen, including substrates a delivered strain depends on. Spacing doses is the only way around it.

L. plantarum carries the transport and hydrolase machinery to ferment short-chain fructans, so FOS acts as a feedstock rather than passing through untouched. Fermentation of that substrate yields lactate and short-chain fatty acids and lowers luminal pH. The pairing is the standard synbiotic construction: an organism plus a carbohydrate the organism can actually use. What a given strain does with a given chain length still varies by strain.

Resistant starch escapes small-intestinal amylase and becomes a colonic fermentation substrate. Cross-feeding is the relevant point: primary degraders release oligosaccharides and lactate that secondary fermenters convert onward to butyrate. L. plantarum sits in that chain as a lactate producer more than a primary starch degrader.

Psyllium is only partially fermented, and its main action is viscosity and water holding rather than feeding a single organism. Alongside a live strain it slows transit, which lengthens the window for fermentation in the proximal colon. The pairing is plausible on physiology and is not grounded in a combination trial here.

Pectin is a fermentable soluble fibre and several lactobacilli carry pectin-derived oligosaccharide utilisation genes. It also forms a gel matrix that can shelter cells during gastric transit. Both effects are mechanistic rather than measured outcomes for this strain.

Guar galactomannan is fermented in the colon and raises viscosity in the small intestine. Paired with a live culture it supplies fermentable carbon distal to the strain's delivery point. This is a mechanism-level pairing, not a trial-level one.

Lactobacilli and bifidobacteria occupy different niches and use partly different carbohydrate sets, which is why multi-strain formulas combine them. Lactate produced by L. plantarum is a substrate for lactate-utilising species further down the chain. Cross-feeding is well described in culture; how much of it happens in any one person's colon is not.

A 2026 report describes gut microbiota modulation with a B. animalis subsp. lactis strain together with L. plantarum, so the two have been studied as a pair rather than only assumed to pair. Microbiota composition is a marker, not a clinical outcome. Strain identity matters and does not transfer between products.

The two species differ in bile tolerance, adhesion behaviour and carbohydrate preference, so combining them widens the range of conditions under which at least one survives transit. Multi-strain blends are built on that logic. Additive benefit over either alone is not established for this pair.

S. boulardii is a yeast, so it is untouched by bacteriocins and by antibacterial agents that would suppress a lactobacillus. That non-overlap is the reason the two are combined in the same capsule. It is a compatibility argument, not evidence of a joint effect.

A randomised study combined a probiotic with iron and folic acid and reported on iron status and gut inflammation markers. Lowering colonic pH through lactate production is the proposed route by which lactic acid bacteria could affect iron handling. Both endpoints there are markers, and an association in that setting is not a demonstrated cause.

Menaquinone production is a known capability of parts of the gut bacterial community, and some lactic acid bacteria contribute small amounts. Bacterial menaquinone made in the colon is poorly absorbed compared with a supplemented dose. The pairing is biochemically real and quantitatively minor.

Zinc is required for tight junction protein assembly and for normal epithelial turnover, which is the same barrier layer a live culture interacts with from the luminal side. The two act on the same structure by different routes. Barrier measures are markers, and no combination trial grounds this pairing.

Lactoferrin sequesters free iron, which restricts iron-scavenging bacteria while lactobacilli have unusually low iron requirements. That asymmetry is the basis for combining the two. It is established chemistry applied to a pairing that has not been measured here.

Allicin and related thiosulfinates are broad antibacterial compounds and do not spare lactic acid bacteria in culture. Taken at the same moment as a live culture, concentrated garlic preparations may reduce the number of organisms that survive to the colon. Separating the doses is the practical response.

Gut bacteria hydrolyse and ring-cleave catechins into smaller phenolic metabolites, and lactobacilli contribute esterase activity to that step. At higher concentrations the same catechins are antibacterial. The direction of the interaction depends on dose, which is why it is filed as modulating rather than additive.

Quercetin glycosides need bacterial glycosidases before the aglycone is available for absorption, and lactic acid bacteria carry those enzymes. A live culture therefore sits upstream of quercetin bioavailability rather than beside it. How much any single strain contributes in vivo is unmeasured.

Gastric acid is the main reason live cells are lost before reaching the intestine, and bicarbonate raises gastric pH for a short window. Delivery systems exploit the same principle with buffered matrices and delayed-release shells. Nothing here quantifies survival gain for this strain.

Dairy protein buffers stomach acid and is the historical matrix in which these organisms were consumed, which is why fermented milk carriers show better cell survival than water in laboratory transit models. The protein is a vehicle, not an active partner. Survival counts are a marker.